Molecular Detection Inc. (MDI) is applying its proprietary technologies to develop and market Detect-Ready® molecular diagnostic tests to increase the speed, accuracy, ease of use, and efficiency of infectious disease diagnosis.
LATEST NEWS:
MOLECULAR DETECTION INC. FURTHER STRENGTHENS PATENT PORTFOLIO BROADLY COVERING DETECTION OF ANTIBIOTIC-RESISTANT BACTERIA
MOLECULAR DETECTION INC. COMPLETES $1.9 MILLION SERIES B FINANCING FOR DETECT-READY® PANELS FOR INFECTIOUS DISEASE DIAGNOSIS
DETECT-READY® MRSA PANEL:
This panel is a ready-to-use, "sample-to-answer" rapid detection screening test for the growing problem of MRSA (methicillin-resistant S. aureus) and related pathogens, which cause costly and potentially deadly infections in hospitals and other health facilities worldwide. The panel is the only product capable of detecting MRSA, MSSA and related infections from mixed samples.
more... 
ABOUT MDI:
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of sample-to-answer Detect-Ready® molecular diagnostic tests for the rapid detection of infectious diseases. MDI recently launched the Detect-Ready MRSA Panel in major European countries and Australia for the rapid diagnosis of MRSA and related infections.

more... 
Copyright 2012 Detect-Ready® and Molecular Detection Inc.Download the Detect-Ready® MRSA Kit Brochure